We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of travoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma.
- Authors
Min Suh; Ki Park; Dong Kim
- Abstract
Abstract Purpose To evaluate the intraocular pressure (IOP)-lowering effect of travoprost in normal-tension glaucoma (NTG) over a 12-month follow-up. Methods Forty-five eyes of 45 patients with unilateral NTG were treated with travoprost (0.004%) once a day for 12 months. Mean IOP and the IOP reduction from baseline were assessed at 0.5, 1, 3, 6, 9, and 12 months after the initiation of the treatment. Adverse ocular event frequency and the frequency of discontinuation of treatment due to adverse events were evaluated. Results Mean IOP during 12 months of travoprost treatment ranged from 11.17 to 11.82 mmHg, and the mean IOP reduction in relation to baseline IOP from −2.71 to −3.71 mmHg (−18.3% to −25.1%). Mean IOP and IOP changes in the travoprost-treated and control groups were significantly different at every follow-up (P r = 0.6992) and percentage (r = 0.5464) of IOP reductions correlated positively with baseline IOP values. Ocular adverse events were usually mild to moderate and resolved without treatment. Conclusions Travoprost was well tolerated and significantly reduced IOP in NTG patients. In addition, initial IOP reductions were maintained throughout follow-up. Travoprost was found to be more effective in patients with greater baseline IOP.
- Subjects
OPHTHALMIC drugs; DRUG efficacy; GLAUCOMA treatment; INTRAOCULAR pressure; REDUCTION of drug dosage; DRUG side effects; OPTIC nerve; DRUG dosage
- Publication
Japanese Journal of Ophthalmology, 2009, Vol 53, Issue 1, p18
- ISSN
0021-5155
- Publication type
Article
- DOI
10.1007/s10384-008-0617-8